325 related articles for article (PubMed ID: 25442261)
1. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells.
Abdelfatah SA; Efferth T
Phytomedicine; 2015 Feb; 22(2):308-18. PubMed ID: 25765838
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomic Characterization of Cytotoxic Compounds from Salvia officinalis in Cancer Cells.
Kadioglu O; Efferth T
J Nat Prod; 2015 Apr; 78(4):762-75. PubMed ID: 25713926
[TBL] [Abstract][Full Text] [Related]
4. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
Song JM; Anandharaj A; Upadhyaya P; Kirtane AR; Kim JH; Hong KH; Panyam J; Kassie F
Oncotarget; 2016 Sep; 7(36):57752-57769. PubMed ID: 27458163
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
[TBL] [Abstract][Full Text] [Related]
7. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
[TBL] [Abstract][Full Text] [Related]
8. Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration.
Yu CP; Li PY; Chen SY; Lin SP; Hou YC
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885972
[TBL] [Abstract][Full Text] [Related]
9. Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis.
Han HK; Van Anh LT
Anticancer Res; 2012 Oct; 32(10):4445-52. PubMed ID: 23060571
[TBL] [Abstract][Full Text] [Related]
10. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
Pick A; Wiese M
ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
13. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
14. Epimagnolin A, a tetrahydrofurofuranoid lignan from Magnolia fargesii, reverses ABCB1-mediated drug resistance.
Mitani Y; Satake K; Tsukamoto M; Nakamura I; Kadioglu O; Teruya T; Yonezawa T; Cha BY; Efferth T; Woo JT; Nakagawa H
Phytomedicine; 2018 Dec; 51():112-119. PubMed ID: 30466608
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
16. Putative molecular determinants mediating sensitivity or resistance towards carnosic acid tumor cell responses.
Mahmoud N; Saeed MEM; Sugimoto Y; Klinger A; Fleischer E; Efferth T
Phytomedicine; 2020 Oct; 77():153271. PubMed ID: 32659679
[TBL] [Abstract][Full Text] [Related]
17. Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1.
Tajima Y; Nakagawa H; Tamura A; Kadioglu O; Satake K; Mitani Y; Murase H; Regasini LO; Bolzani Vda S; Ishikawa T; Fricker G; Efferth T
Phytomedicine; 2014 Feb; 21(3):323-32. PubMed ID: 24135452
[TBL] [Abstract][Full Text] [Related]
18. New mechanism of magnolol and honokiol from Magnolia officinalis against Staphylococcus aureus.
Liu T; Pan Y; Lai R
Nat Prod Commun; 2014 Sep; 9(9):1307-9. PubMed ID: 25918799
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drug-sensitive and multidrug-resistant cancer cells.
Ochwang'i DO; Kimwele CN; Oduma JA; Gathumbi PK; Kiama SG; Efferth T
J Ethnopharmacol; 2018 Apr; 215():233-240. PubMed ID: 29309859
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of sesquiterpene alkaloids from Nuphar plants toward sensitive and drug-resistant cell lines.
Fukaya M; Nakamura S; Hegazy MEF; Sugimoto Y; Hayashi N; Nakashima S; Yoshikawa M; Efferth T; Matsuda H
Food Funct; 2018 Dec; 9(12):6279-6286. PubMed ID: 30406781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]